News
News
Strategic appointments for VitaDX with the nomination of Hilja Ibert and Sébastien Dias to its board of directors
17 septembre 2024 -
VitaDX selected by Pfizer and WILCO to be part of the new #PfizerHealthcareHub France promo
16 janvier 2024 -
Avero Diagnostics and VitaDX announce the signing of a strategic partnership for the distribution in the United States of VisioCyt® Bladder, a diagnostic test for bladder cancer
18 décembre 2023 -
Launch of the participatory financing campaign!
14 novembre 2023 -
It's official: the Sowefund crowdfunding campaign is now public and open to all!…
VitaDX wins France2030's "Medical Imaging" call for projects!
18 octobre 2023 -
VisioCyt® on TF1!
8 juin 2023 -
A big thank you to the TF1 Group for this report broadcast on June 07, 2023 on the 8:00 pm news, showing the benefits of Artificial Intelligence…
Strategic appointments for VitaDX with the nomination of Hilja Ibert and Sébastien Dias to its board of directors
17 septembre 2024 -
VitaDX selected by Pfizer and WILCO to be part of the new #PfizerHealthcareHub France promo
16 janvier 2024 -
Avero Diagnostics and VitaDX announce the signing of a strategic partnership for the distribution in the United States of VisioCyt® Bladder, a diagnostic test for bladder cancer
18 décembre 2023 -
Launch of the participatory financing campaign!
14 novembre 2023 -
It's official: the Sowefund crowdfunding campaign is now public and open to all!…
VitaDX wins France2030's "Medical Imaging" call for projects!
18 octobre 2023 -
VisioCyt® on TF1!
8 juin 2023 -
A big thank you to the TF1 Group for this report broadcast on June 07, 2023 on the 8:00 pm news, showing the benefits of Artificial Intelligence…